Literature DB >> 23548499

Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.

Simon D S Fraser1, Paul J Roderick, Natasha J McIntyre, Scott Harris, Christopher W McIntyre, Richard J Fluck, Maarten W Taal.   

Abstract

BACKGROUND/AIMS: For most people with chronic kidney disease (CKD), cardiovascular disease (CVD) risk exceeds risk of progression to end-stage renal disease. This study aimed to investigate the distribution of cardiovascular risk in CKD stage 3 by socio-economic status (SES; measured by area deprivation and educational attainment) and CKD diagnosis awareness.
METHODS: 1,741 patients with CKD 3 recruited from primary-care practices for the Renal Risk in Derby Study were assessed for cardiovascular risk factors. Ten-year cardiovascular risk, estimated using Framingham and QRISK2 risk prediction algorithms in eligible subgroups, was dichotomised at ≥ 20% (a threshold for clinical action in the UK), and compared by SES and awareness of CKD diagnosis using logistic regression.
RESULTS: Patients with lower SES had greater adjusted odd ratios (OR) of smoking, diabetes and previous CVD, but not of central obesity, hypertension, elevated total/high-density-lipoprotein cholesterol ratio or albuminuria. Using Framingham scoring (n = 672), the adjusted OR of having ≥ 20% 10-year risk were 2.87 [95% confidence interval (CI) 1.41-5.84] in the lowest deprivation quintile compared to the highest, 2.52 (95% CI: 1.52-4.00) in those without qualifications compared to those with qualifications, and 1.54 (95% CI: 1.09-2.17) in those unaware of their CKD diagnosis compared to those aware of it. QRISK2 scoring (n = 1,071) showed a similar association with education status [OR: 2.45 (95% CI: 1.63-3.67)] and lack of CKD awareness [OR: 1.46 (95% CI: 1.05-2.03)], but not with deprivation [OR: 1.12 (95% CI: 0.55-2.27)].
CONCLUSION: An elevated CVD risk is associated with a lower education status and lack of awareness of CKD diagnosis in people with CKD 3.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23548499     DOI: 10.1159/000348835

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  4 in total

1.  JOINT MEAN AND COVARIANCE MODELING OF MULTIPLE HEALTH OUTCOME MEASURES.

Authors:  Xiaoyue Niu; Peter D Hoff
Journal:  Ann Appl Stat       Date:  2019-04-10       Impact factor: 2.083

2.  Cardiovascular risk using WHO-ISH chart among Diabetes and Hypertensive patients in a remote rural area of South India.

Authors:  David Gregg Smith Ponraj; Sri Keerthana Gopikrishnan; Ariarathinam Newtonraj; Mark Christopher Arokiaraj; Anil Jacob Purty; Sunil Kumar Nanda; Mani Manikandan; Antony Vincent
Journal:  J Family Med Prim Care       Date:  2020-08-25

3.  Skin autofluorescence and all-cause mortality in stage 3 CKD.

Authors:  Simon D S Fraser; Paul J Roderick; Natasha J McIntyre; Scott Harris; Christopher W McIntyre; Richard J Fluck; Maarten W Taal
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 8.237

4.  Predictors of patient self-report of chronic kidney disease: baseline analysis of a randomised controlled trial.

Authors:  Hannah Gaffney; Thomas Blakeman; Christian Blickem; Anne Kennedy; David Reeves; Shoba Dawson; Rahena Mossabir; Peter Bower; Caroline Gardner; Victoria Lee; Anne Rogers
Journal:  BMC Fam Pract       Date:  2014-11-30       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.